Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NoHo Partners Plc: Managers’ Transactions (Virlander)

NoHo Partners Plc, Managers’ Transactions, 4 October 2024 at 16:00 EET NoHo Partners Plc: Managers’ Transactions (Virlander) ____________________________________________ Person subject to the notification requirementName: Henri VirlanderPosition: Other senior manager Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 80395/7/6 ____________________________________________ Transaction date: 2024-10-03Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000064332Nature of transaction:

NoHo Partners Plc: Managers’ Transactions (Koivula)

NoHo Partners Plc, Managers’ Transactions, 4 October 2024 at 16:00 EET NoHo Partners Plc: Managers’ Transactions (Koivula) ____________________________________________ Person subject to the notification requirementName: Maria KoivulaPosition: Other senior manager Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 80398/5/4 ____________________________________________ Transaction date: 2024-10-04Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000064332Nature of transaction: ACQUISITION

NoHo Partners Plc: Managers’ Transactions (Meli)

NoHo Partners Plc, Managers’ Transactions, 4 October 2024 at 16:00 EET NoHo Partners Plc: Managers’ Transactions (Meli) ____________________________________________ Person subject to the notification requirementName: Paul MeliPosition: Other senior manager Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 80394/9/14 ____________________________________________ Transaction date: 2024-10-02Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI4000064332Nature of transaction: DISPOSAL

NoHo Partners Plc: Managers’ Transactions (Paul Meli Holdings Oy)

NoHo Partners Plc, Managers’ Transactions, 4 October 2024 at 16:00 EET NoHo Partners Plc: Managers’ Transactions (Paul Meli Holdings Oy) ____________________________________________ Person subject to the notification requirementName: Paul Meli Holdings OyPosition: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In IssuerName: Paul MeliPosition: Other senior manager Issuer: NoHo Partners OyjLEI: 743700DYZ6R1QNLWQA56Notification type: INITIAL NOTIFICATIONReference number: 80404/6/6 __________________________________

Katalysen Ventures continues to increase its stake in InvitePeople

Katalysen Ventures AB (publ) (“Katalysen”) is pleased to announce that it has been increasing its stake in Matchmeeting AB (“InvitePeople”). Katalysens total stake in InvitePeople is now approximately 16.9% of which around 14.8% is through shares.Katalysen is expecting both significant short- and long-term results from its investment in InvitePeople, a leader in hybrid event software for enterprises. With over 100 clients, including major brands like IKEA and Deutsche Bahn, and a strong presence in the Swedish and German markets, InvitePeople is well-positioned for growth and the ongoing

Election committee for Vitrolife AB (publ)

The following people have been appointed as members of the election committee for Vitrolife AB for the Annual General Meeting in 2025: Niels Jacobsen, appointed by William Demant Invest A/SPatrik Tigerschiöld, appointed by Bure Equity ABPatricia Hedelius, appointed by AMF Fonder & PensionJón Sigurdsson, Chairman of the Board The appointments have been made in accordance with the instructions regarding principles for the appointment of the company election committee which were determined at the Annual General Meeting of Vitrolife AB on April 25, 2024.The Annual General Meeting

Spermosens recruits first couple for clinical study on next-generation male fertility diagnostic product

Spermosens AB (“Spermosens” or the “Company”) is pleased to announce a significant milestone in its clinical study of the next-generation fertility diagnostic product. The first couple has now been recruited for the study, which is designed to assess the diagnostic value of JUNO-Checked in male infertility. The clinical study, currently underway at the Reproductive Medicine Center (RMC) in Malmö, follows ethical approval for the study. Spermosens’ next-generation device, developed in collaboration with Flex Medical Solutions (FMS), features improved performance and faster read-out times,

Munters announces changes in the Group Executive Management Team

Munters announces today that Stefan Måhl, Group Vice President Business Excellence, has decided to leave the company. Stefan Måhl has held his current position since 2020 and has worked at Munters for nearly 20 years in various leadership positions. He will leave Munters to retire on January 15, 2025."With his industry knowledge, drive, and strong commitment, Stefan has contributed significantly to Munters growth journey and innovative progress. Both I and the colleagues at Munters will miss him as he enters a new phase in life," says Klas Forsström, CEO and Group President of Munters. "

Inside information: Bioretec updates its financial targets

Bioretec Ltd  Company announcement 4 October 2024 at 2:31 p.m. EESTBioretec Ltd announced today, 4 October 2024, that Bioretec's board of directors had decided to update the company's product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody Cage following the granting of Breakthrough Device Designation status by the US Food and Drug Administration on 14 March 2024. Due to the acceleration of the product development of the RemeOs™ Spinal Interbody Cage, Bioretec's Board of Directors has today updated Bioretec's financial targets as follows:

Inside information: Bioretec updates its product development strategy by accelerating the product development of RemeOs™ Spinal Interbody Cage

Bioretec Ltd Company announcement 4 October 2024 at 2:30 p.m. EESTBioretec updates its product development strategy by accelerating the product development of the RemeOs™ Spinal Interbody Cage, an innovative medical device engineered from a multifunctional, MRI-compatible, absorbable hybrid composite based on the company's proprietary magnesium alloy. The decision to accelerate the product development of the RemeOs™ Spinal Interbody Cage is based on an evaluation by the company following the granting of Breakthrough Device designation by the US Food and Drug Administration on March 2024.

Pemamek Iberia celebrates successful Grand Opening of new facilities in Zaragoza

Pemamek, a global leader in welding automation, is proud to announce the successful inauguration of its new facilities in Zaragoza, marking a significant milestone in the company’s ongoing expansion into the Spanish and Portuguese markets. The event, held on October 1, 2024, gathered representatives from the Government of Aragón, the City of Zaragoza, the Ambassador of Finland to Spain, and key industry professionals.[Majority of the event speakers gathered in a group photo From the left Juha Mkitalo CEO Pemamek Oy Roberto Dominguez CEO Arasol Industrial Peter Senz Sales Director Pemamek

Updated time for publication of financial reports and invitation to Q3 presentation

Eastnine has updated the time for publication of upcoming financial reports and report presentation according to the following: · Interim report January–September 2024 will be published on 24 October 2024 at 14.00 CET and report presentation will be held at 15.00 CET on the same day. · Year-end report January–December 2024 will be published on 5 February 2025 at 14.00 CET and report presentation will be held at 15.00 CET on the same day. Presentation of interim report January–September 2024 Eastnine invites investors, analysts and media to a live presentation of the interim

Oxcia is focusing the development of OXC-101 on hematological cancers

Following a strategy and data review, Oxcia has chosen to re-prioritize the clinical development of OXC-101 from solid tumors to hematological cancers, specifically acute myeloid leukemia (AML). The preclinical program for OXC-101 has shown good results in both AML and other forms of hematological cancers, and data to date from the phase I/II study MAATEO confirm the previous results. Oxcia has initiated an expansion part of the MAATEO study in patients with refractory/relapsed AML (R/R AML), where OXC-101 is administered in combination with idarubicin (an anthracycline). - The first AML

Prisma Properties signs long lease agreement with Dollarstore in Växjö

On September the 27th, Prisma Properties (publ) signed a 10-year lease agreement with Dollarstore in Växjö, Sweden. The lease covers a store of 3,890 square meters, where Dollarstore will take over from the previous tenant, XXL.Dollarstore will relocate from its current store in Växjö to Prisma’s retail park in Samarkand. The new store is planned to open in March 2025. “Dollarstore has long been an important partner for us, and with this new store, we further strengthen our retail park with a strong discount tenant. The fact that Dollarstore is taking over the entire space immediately

SOFTSWISS Steps In to Assist Southern Poland After Severe Flooding

SOFTSWISS , a global tech supplier of software for the iGaming industry, along with its employees, has actively aided communities affected by the recent flooding in Southern Poland.In September, Storm Boris brought devastating floods to Central and Eastern Europe, causing widespread damage. Torrential rains left thousands of homes submerged, severely impacting numerous cities in Poland, the Czech Republic, and Romania. In Poland, the southern regions were hit the hardest, with dozens of towns requiring urgent evacuations and support for affected communities.

Helsinki Baltic Herring Market Kicks off Helsinki's Autumn Season

Baltic Herring market is held by the sea. Image source: City of Helsinki / City Environment Sector Helsinki Baltic Herring Market will be held at the Market Square on 6–12 October. The event honours Helsinki's autumn traditions and brings together fishers and many other vendors of artisanal products from around Finland. The Market offers visitors a chance to enjoy products from the Baltic Sea in a maritime market atmosphere. The Baltic herring jury will select the best Baltic herring products of the year on the opening day of the Market.  Helsinki Baltic Herring Market has

Neste strengthens chemical recycling logistics infrastructure in Europe in cooperation with Tepsa Netherlands

Neste Corporation, Press Release, 4 October 2024 at 1 p.m. (EET) Photo: Terminal of Tepsa Netherlands in Rotterdam. Source: Tepsa NetherlandsNeste enhances its chemical recycling capabilities by collaborating with Tepsa Netherlands on the storage and handling of liquefied waste plastic in Rotterdam, the Netherlands. This partnership, focused on the implementation of advanced aggregation tanks, underscores the company's commitment to expanding its liquefied waste plastic processing capabilities and advancing the circular economy. Following successful industrial-scale processing

Announcement of a Change in Shareholding According to Chapter 9, Section 10 of the Finnish Securities Market Act

Sitowise Group Plc Stock Exchange Release 4 October 2024 at 12.45 p.m. (EEST) Sitowise Group Plc (the "Company") has on 3 October 2024 received a notification in accordance with the Chapter 9, Section 10 of the Finnish Securities Market Act from Morgan Stanley, according to which Morgan Stanley & Co International Plc's holding of the shares and votes of the Company increased to 11.15 percent on 2 October 2024. According to the notification, Morgan Stanley holds indirectly a total of 2,215,515 shares corresponding to 6.18 percent of the Company’s shares and votes, and a total of 1,779,

Sitowise Group Oyj - Managers' Transactions - Heliövaara

Sitowise Group Plc                     Managers' transactions           4 October 2024 at 12.40 p.m. EEST Sitowise Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Eero Heliövaara Position: Member of the Board/Deputy member  Issuer: Sitowise Oyj LEI: 743700HOHMOHAANHFF73 Notification type: INITIAL NOTIFICATION Reference number: 80310/5/6 ____________________________________________ Transaction date: 2024-10-01 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN:

Form 8.3 - Anglogold Ashanti Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +--------------------------------------------------------+---------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+--------------------------------------------------------+---------------------+|(b) Owner or controller of interests and short positions|  ||disclosed, if different from 1(a):

SCANDINAVIAN AIRLINES, SAS, AND VIRGIN ATLANTIC ANNOUNCE CODESHARE PARTNERSHIP

· Codeshare between the two SkyTeam carriers will be launched on October 7[th].   · The partnership will introduce exciting new destinations, including Barbados, Antigua and Jamaica.SAS and Virgin Atlantic are delighted to announce a new codeshare agreement, strengthening vital business and leisure connections to and from Scandinavia.     The codeshare partnership, launching on October 7th, will allow SAS customers to connect via Heathrow to additional Virgin Atlantic’s destinations, with availability expanding as approvals are finalized. Virgin Atlantic customers travelling on

ProTrans highlighted as a promising treatment for type 1 diabetes in Dagens Medicin

NextCell Pharma AB* is proud that their drug candidate ProTrans has been highlighted in Dagens Medicin’s latest edition featuring ongoing research advances in the treatment of type 1 diabetes. ProTrans consists of mesenchymal stromal cells from the umbilical cord and has been investigated in a number of clinical studies at Uppsala University Hospital, where its potential to slow down the progression of the disease has been demonstrated.Articles in Dagens Medicin (2024-09-25) underline the need to protect insulin-producing beta cells and delay the development of type 1 diabetes, an

Lagercrantz’ share-based incentive programme fully subscribed

The Annual General Meeting 2024 decided on a call option programme on repurchased class B shares, for Lagercrantz’ managers and senior executives. The share-based incentive programme of 800,000 call options has been fully subscribed by some 79 senior executives. The call options are transferred at a price of SEK 22.65 per call option, equivalent to the market value according to an external independent valuation, applying the Black & Scholes model. The exercise price amounts to SEK 233.90, which is equivalent to 125 percent of the average market price during the measuring period 3

Notification according to chapter 9, section 10 of the Securities Market Act

UPM-Kymmene Corporation Stock Exchange Release (Flagging Release) 4 October 2024 at 10:25 EEST Notification according to chapter 9, section 10 of the Securities Market Act UPM-Kymmene Corporation has on 2 October 2024 received a notification according to Chapter 9, Section 5 of the Securities Markets Act in which BlackRock, Inc. announces Group restructure following the acquisition of Global Infrastructure Management LLC. Total positions of BlackRock, Inc. and its funds: +----------------+----------+------------------+------+------------+|  |% of |% of

There are no items matching the current filter
There are no more items matching the current filter
Back to top